When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Blueprint Medicine's Most Recent Raise Is A Necessary Desperation
Deciphera Pharmaceuticals Inc.
Blueprint's (Most Recent) Raise
Closed: TBD (proposed pricing on 1/22/20)
Pricing: $69.00/share
Amount: ~$325 million
Over-allotment: TBD
Blueprint Medicines (BPMC) recently announced a dilutive raise, sending share prices below key moving averages:
Blueprint's last raise was in March 2019 and priced at $74/share, $5/share higher than the most recent offering. Of course, this is never favorable, but in this case may be a necessary desperation. The company figures to increase an already good amount of R&D spending. Couple this with commercialization pegged to begin this year and you have the need for